An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in miceTimothy P. Sheahan, Ralph S. Baric, James D. Chappell et al.|Science Translational Medicine|2020Cited by 1.2k
Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in MiceAndrea J. Pruijssers, Timothy P. Sheahan, Amelia S. George et al.|Cell Reports|2020Cited by 541
Mutations in the SARS-CoV-2 RNA-dependent RNA polymerase confer resistance to remdesivir by distinct mechanismsLaura J. Stevens, Mark R. Denison, Andrea J. Pruijssers et al.|Science Translational Medicine|2022Cited by 258
Remdesivir potently inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in miceAndrea J. Pruijssers, Timothy P. Sheahan, Amelia S. George et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 36
Distinct genetic determinants and mechanisms of SARS-CoV-2 resistance to remdesivirLaura J. Stevens, Mark R. Denison, Hery W. Lee et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 6